Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2006 2
2007 2
2008 2
2009 1
2010 2
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Mouse models of cancer.
Cheon DJ, Orsulic S. Cheon DJ, et al. Annu Rev Pathol. 2011;6:95-119. doi: 10.1146/annurev.pathol.3.121806.154244. Annu Rev Pathol. 2011. PMID: 20936938 Review.
Modeling resistance to pathway-targeted therapy in ovarian cancer.
Xing D, Orsulic S. Xing D, et al. Cell Cycle. 2005 Aug;4(8):1004-6. doi: 10.4161/cc.4.8.1869. Epub 2005 Aug 25. Cell Cycle. 2005. PMID: 15970711 Free PMC article. Review.
A role for BRCA1 in uterine leiomyosarcoma.
Xing D, Scangas G, Nitta M, He L, Xu X, Ioffe YJ, Aspuria PJ, Hedvat CY, Anderson ML, Oliva E, Karlan BY, Mohapatra G, Orsulic S. Xing D, et al. Cancer Res. 2009 Nov 1;69(21):8231-5. doi: 10.1158/0008-5472.CAN-09-2543. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843854 Free PMC article.
HOXB13 promotes ovarian cancer progression.
Miao J, Wang Z, Provencher H, Muir B, Dahiya S, Carney E, Leong CO, Sgroi DC, Orsulic S. Miao J, et al. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17093-8. doi: 10.1073/pnas.0707938104. Epub 2007 Oct 17. Proc Natl Acad Sci U S A. 2007. PMID: 17942676 Free PMC article.
Hippo pathway effector Yap is an ovarian cancer oncogene.
Hall CA, Wang R, Miao J, Oliva E, Shen X, Wheeler T, Hilsenbeck SG, Orsulic S, Goode S. Hall CA, et al. Cancer Res. 2010 Nov 1;70(21):8517-25. doi: 10.1158/0008-5472.CAN-10-1242. Epub 2010 Oct 14. Cancer Res. 2010. PMID: 20947521 Free PMC article.
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
Wang Y, Cheon DJ, Lu Z, Cunningham SL, Chen CM, Luo RZ, Xing D, Orsulic S, Bast RC Jr, Behringer RR. Wang Y, et al. Differentiation. 2008 Dec;76(10):1081-92. doi: 10.1111/j.1432-0436.2008.00295.x. Epub 2008 Jul 2. Differentiation. 2008. PMID: 18637025 Free PMC article.
Models of ovarian cancer metastasis: Murine models.
Sale S, Orsulic S. Sale S, et al. Drug Discov Today Dis Models. 2006 Jun 1;3(2):149-154. doi: 10.1016/j.ddmod.2006.05.006. Drug Discov Today Dis Models. 2006. PMID: 19337569 Free PMC article.
Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells.
Chaudhuri D, Orsulic S, Ashok BT. Chaudhuri D, et al. Mol Cancer Ther. 2007 Jan;6(1):334-45. doi: 10.1158/1535-7163.MCT-06-0404. Mol Cancer Ther. 2007. PMID: 17237292 Free PMC article.
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance.
Xing D, Orsulic S. Xing D, et al. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6936-41. doi: 10.1073/pnas.0502256102. Epub 2005 Apr 28. Proc Natl Acad Sci U S A. 2005. PMID: 15860581 Free PMC article.
14 results
Jump to page